CB Scientific, Inc.
OTC:CBSC
0.1347 (USD) • At close November 17, 2023
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Omzet
| 0.135 | 0.082 | 0.076 | 0.032 | 0.122 | 0.059 | 0.037 | 0.033 |
| Kosten van de omzet
| 0 | 0.042 | 0.149 | 0.01 | 0.72 | 0.044 | 0.415 | 0.227 |
| Brutowinst
| 0.135 | 0.04 | -0.074 | 0.023 | -0.598 | 0.015 | -0.378 | -0.194 |
| Brutowinstmarge
| 1 | 0.487 | -0.975 | 0.698 | -4.905 | 0.253 | -10.326 | -5.9 |
| Onderzoek- en ontwikkelingskosten
| 0.42 | 0.485 | 0 | 0 | 0 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 1.311 | 2.142 | 1.797 | 2.958 | 0 | 0 | 0 | 0 |
| Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0.089 | 0.16 |
| Verkoop-, algemene en administratieve kosten
| 1.311 | 2.142 | 1.797 | 2.958 | 0.318 | 0.077 | 0.089 | 0.16 |
| Overige kosten
| 0 | 0 | 0 | 0 | -0.083 | 0 | -0.014 | -0.015 |
| Bedrijfskosten
| 1.731 | 2.142 | 1.797 | 2.965 | 0.401 | 0.077 | 0.103 | 0.175 |
| Bedrijfsresultaat
| -1.596 | -2.102 | -1.871 | -2.943 | -0.999 | -0.063 | -0.481 | -0.37 |
| Bedrijfsresultaat ratio
| -11.815 | -25.507 | -24.754 | -90.715 | -8.197 | -1.067 | -13.149 | -11.222 |
| Totaal overige inkomsten en kosten netto
| -0.035 | -0.005 | -4.471 | -1.385 | 0 | 0 | -0.65 | -0.016 |
| Inkomen voor belasting
| -1.63 | -2.107 | -6.342 | -4.328 | -0.999 | -0.063 | -1.131 | -0.386 |
| Inkomen voor belasting ratio
| -12.071 | -25.564 | -83.919 | -133.414 | -8.197 | -1.066 | -30.903 | -11.715 |
| Belastingkosten
| 0 | -0.228 | 1.544 | 0.344 | -0.172 | -0 | -0 | -0 |
| Nettowinst
| -1.63 | -2.107 | -6.342 | -4.328 | -0.999 | -0.063 | -1.131 | -0.386 |
| Nettowinstmarge
| -12.071 | -25.564 | -83.919 | -133.414 | -8.197 | -1.066 | -30.903 | -11.715 |
| WPA (Winst Per Aandeel)
| -0.012 | -0.018 | -0.07 | -0.056 | -0.017 | -0.001 | -0.02 | -0.007 |
| Verwaterde WPA
| -0.012 | -0.018 | -0.07 | -0.056 | -0.017 | -0.001 | -0.02 | -0.007 |
| EBITDA
| -1.625 | -2.101 | -4.798 | -3.977 | -0.999 | -0.06 | -1.128 | -0.369 |
| EBITDA ratio
| -12.032 | -25.501 | -63.484 | -122.592 | -8.197 | -1.015 | -30.812 | -11.207 |